Literature DB >> 1576045

Measuring the frequency of adverse drug reactions.

P C Waller1.   

Abstract

Mesh：

Year:  1992        PMID： 1576045      PMCID： PMC1381271          DOI： 10.1111/j.1365-2125.1992.tb04031.x

Source DB:  PubMed          Journal:  Br J Clin Pharmacol        ISSN： 0306-5251            Impact factor:   4.335


× No keyword cloud information.
  12 in total

1.  Validation of information recorded on general practitioner based computerised data resource in the United Kingdom.

Authors:  H Jick; S S Jick; L E Derby
Journal:  BMJ       Date:  1991-03-30

2.  A comparison of the risk of hypoglycemia between users of human and animal insulins. 1. Experience in the United Kingdom.

Authors:  H Jick; G C Hall; A D Dean; S S Jick; L E Derby
Journal:  Pharmacotherapy       Date:  1990       Impact factor: 4.705

Review 3.  The role of automated record linkage in the postmarketing surveillance of drug safety: a critique.

Authors:  S Shapiro
Journal:  Clin Pharmacol Ther       Date:  1989-10       Impact factor: 6.875

4.  The future of automated record linkage for postmarketing surveillance: a response to Shapiro.

Authors:  G A Faich; B V Stadel
Journal:  Clin Pharmacol Ther       Date:  1989-10       Impact factor: 6.875

5.  Uninformed criticism of automated record linkage.

Authors:  H Vick; A M Walker
Journal:  Clin Pharmacol Ther       Date:  1989-10       Impact factor: 6.875

6.  An algorithm for the operational assessment of adverse drug reactions. I. Background, description, and instructions for use.

Authors:  M S Kramer; J M Leventhal; T A Hutchinson; A R Feinstein
Journal:  JAMA       Date:  1979-08-17       Impact factor: 56.272

7.  Postmarketing surveillance of enalapril. I: Results of prescription-event monitoring.

Authors:  W H Inman; N S Rawson; L V Wilton; G L Pearce; C J Speirs
Journal:  BMJ       Date:  1988-10-01

8.  Persistent dry cough with enalapril: incidence depends on method used.

Authors:  W W Yeo; L E Ramsay
Journal:  J Hum Hypertens       Date:  1990-10       Impact factor: 3.012

9.  Prescription-event monitoring: methodology and recent progress.

Authors:  N S Rawson; G L Pearce; W H Inman
Journal:  J Clin Epidemiol       Date:  1990       Impact factor: 6.437

10.  Postmarketing surveillance of the safety of cimetidine: 12 month mortality report.

Authors:  D G Colin-Jones; M J Langman; D H Lawson; M P Vessey
Journal:  Br Med J (Clin Res Ed)       Date:  1983-05-28
View more
  6 in total

1.  Frequency of adverse drug reactions.

Authors:  A DeBoer
Journal:  Br J Clin Pharmacol       Date:  1993-07       Impact factor: 4.335

Review 2.  The epidemiology of serious adverse drug reactions among the elderly.

Authors:  P A Atkin; P C Veitch; E M Veitch; S J Ogle
Journal:  Drugs Aging       Date:  1999-02       Impact factor: 3.923

3.  Adverse events associated with rofecoxib therapy: results of a large study in community-derived osteoarthritic patients.

Authors:  Bernard Bannwarth; Richard Trèves; Liana Euller-Ziegler; Denis Rolland; Philippe Ravaud; Maxime Dougados
Journal:  Drug Saf       Date:  2003       Impact factor: 5.606

Review 4.  Drug-induced hepatic disorders. Incidence, management and avoidance.

Authors:  M Døssing; J Sonne
Journal:  Drug Saf       Date:  1993-12       Impact factor: 5.606

Review 5.  Antithyroid drug-induced agranulocytosis: clinical experience with ten patients treated at one institution and review of the literature.

Authors:  M Meyer-Gessner; G Benker; S Lederbogen; T Olbricht; D Reinwein
Journal:  J Endocrinol Invest       Date:  1994-01       Impact factor: 4.256

6.  Vestibulotoxicity Associated With Platinum-Based Chemotherapy in Survivors of Cancer: A Scoping Review.

Authors:  Pattarawadee Prayuenyong; John A Taylor; Stephanie E Pearson; Rachel Gomez; Poulam M Patel; Deborah A Hall; Anand V Kasbekar; David M Baguley
Journal:  Front Oncol       Date:  2018-09-25       Impact factor: 6.244
  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.